
Emily Kendall
@emilyakendall
Infectious diseases physician & Associate Prof @johnshopkins. Tuberculosis, disease dynamics, global health.
ID: 1458309072
26-05-2013 00:03:26
88 Tweet
384 Followers
427 Following

In “Ending TB in a post-COVID-19 world: a person-centred, equity-oriented approach”, out this week in The Lancet Infectious Diseases, we explore how to center TB programs around personal experiences and upstream disparities, which we argue will be critical in the fight to #EndTB 1/5


Multiple Postdocs (Baltimore, USA) Infectious Disease Modeling to Inform Public Health Policy with Todd Fojo Emily Kendall Sourya Shrestha David Dowdy at Johns Hopkins Department of Medicine Johns Hopkins Bloomberg School of Public Health More details: iddjobs.org/jobs/infectiou…

Interested in policy-relevant modeling of TB and/or HIV? We're four Johns Hopkins University PIs jointly recruiting post-docs to our TB/HIV/ID modeling team. Lots of flexibility to tailor the training experience to individual interests and career goals. We'd love to hear from you!

Congratulations to Hanif Esmail Bianca Sossen Rein Houben on this analysis of the historical literature to understand the natural history of early TB. Very fun to write with Emily Kendall about the implications for modern community-based screening. #WorldTBDay2023

TB Science abstract submission is now open! The Union Conference #tbscience Please share widely! conf2023.theunion.org/tb-science/?ut…

New work in The Lancet Global Health showing how improvements to TB treatment regimens could offset higher drug costs by improving care and reducing costs for patients and health systems: bit.ly/3yyHRmI. Work was led by Tess Ryckman and informed WHO's target TB regimen profiles.
